Elena Gershtein

Senior researcher, professor, Head of Receptor and Biomarker Study Group
Institute of Clinical Oncology, Laboratory of Clinical Biochemistry
Russian N.N.Blokhin Cancer Research Center RAMS
E-mail: esgershtein@gmail.com

Fields of interest:

Tumor biological markers
Cellular signaling
Mechanisms of metastasizing and angiogenesis

Recent publications (selected):

N.E. Kushlinsky, E.S. Gershtein:
Tumor biological markers in the clinic – achievements, problems, prospects,
Molecularnaya Medicina, Vol. 3, (2008), pp. 48-55.

E.S. Gershtein, E.A. Korotkova, V.V. Prorokov, N.E. Kushlinsky:
Matrix metalloproteinases 2, 3, 13 and their type 2 tissue inhibitor in tumors and plasma of patients with colorectal
cancer,
Bulletin of Experimental Biology and Medicine, Vol. 145(3), (2008), pp. 362-366.

E.S. Gershtein, N.E. Kushlinskii:
Contemporary overview of the mechanisms of growth factor signaling as the basis for effective targeted antitumor
therapy,
Vopr. Biol. Med. Pharm. Khimii, Vol. 1, 2007, N1, pp.4-9

E.S. Gershtein, A.M. Scherbakov, V.A. Shatskaya et al:
Phosphatidylinositol 3-kinase/AKT signalling pathway components in human breast cancer: clinico-pathological correlations,
Anticancer Research, 2007, v.27, N4А, p. 1777-1782.

A.M. Scherbakov, Y.S. Lobanova, V.A. Shatskaya, E.S. Gershtein et al.:
Activation of mitogenic pathways and sensitization to estrogen-induced apoptosis: two independent characteristics of tamoxifen-resistant breast cancer
cells?,
Breast Cancer Res. Treat., Vol. 100(1), (2006), pp. 1-11.

E.S. Gershtein, A.M. Scherbakov, O.A. Anurova et al.:
Phosphorylated Akt1 in human breast cancer measured by direct sandwich enzyme-linked immunosorbent
assay: Correlation with clinicopathological features and tumor VEGF-signaling system component
levels,
Int. J. Biol. Markers, Vol. 21(1), (2006), pp. 12-19.

]A.M. Shcherbakov, E.S. Gershtein, O.A. Anurova and N.E. Kushlinskii.:
Activated proteinkinase B in breast cancer,
Bull. Exp. Biol. Med., Vol. 139(5), (2005), pp. 608-610.